Active Not Recruiting OBSERVATIONAL NCT05972785

Long-term Use of CCB and Breast Cancer Risk

Association of Long-term Use of Calcium Channel Blockers (CCB) and Risk of Breast Cancer: A Retrospective Longitudinal Observational Study

Sponsor: Curtin University

Conditions Breast Cancer Hypertension,Essential

Interventions Beta blocker Calcium channel blocker Diuretic None AHT Other AHT RAS

Updated 3 times since 2023 Last updated: Aug 20, 2024 Started: Jul 1, 2022 Primary completion: Jun 30, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer and Hypertension,Essential, this trial is ongoing. The trial is conducted by Curtin University and has accumulated 3 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Sep 2023 — Jul 2024 [monthly]

Active Not Recruiting

First recorded

Jul 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Curtin University

Data source: Curtin University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bentley, Australia